RDEA study supports development of new NNRTI.
D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
D018894:Reverse Transcriptase Inhibitors